Lot-to-Lot Consistency and Bridging Study of a Tetravalent Dengue Vaccine in Healthy Adults in Australia.
Phase of Trial: Phase III
Latest Information Update: 14 Sep 2017
At a glance
- Drugs CYD TDV (Primary)
- Indications Dengue
- Focus Pharmacodynamics; Registrational
- Sponsors sanofi pasteur
- 14 Sep 2017 Results of a substudy published in the Journal of Infectious Diseases
- 02 Aug 2012 Planned End Date changed from 1 Oct 2012 to 1 Oct 2013 as reported by ClinicalTrials.gov.
- 29 Nov 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.